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The main goal of the present document is to provide a set of practical recommendations for ultrasound imagers who are interested in ar-
tery diseases or for physicians who intend to undertake vascular procedures. This is the first part of the work. It is dedicated to general
principles of ultrasonography, cervicoencephalic, subclavian, aortoiliac and lower extremity arteries, abdominal aorta, and popliteal aneur-
ysms. It also discusses miscellaneous items such as medial arterial calcinosis, arterial embolism, arteritis, arterial stents and bypasses, false
aneurysms, aortic dissection, popliteal entrapment syndrome, and iliac endofibrosis.
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Introduction
Currently non-invasive vascular imaging includes Duplex ultrasonog-
raphy (DUS), computed tomography (CT), magnetic resonance
imaging (MRI), and less used techniques such as transcutaneous oxy-
gen tension (TcPO2), laser Doppler, capillaroscopy, positron emis-
sion tomography (PET), and nuclear lymphography. Angiography is
no longer the gold standard, and is mostly limited to endovascular
procedures (i.e. stenting) or very peculiar diagnoses. Compared with
other vascular imaging techniques, DUS has many advantages: low
cost, safety, availability, haemodynamic data, physiological testing, and
is most of the time the first-line imaging technique. The main goal of
the present document is to provide a set of practical recommenda-
tions for imagers who are involved in cardiovascular (CV) diseases or
perform vascular procedures. Non-invasive cardiologists may also be
interested in getting more familiar to vascular DUS.
This is the first part of the document. It should be considered as a
complement to the ESC-ESVS guidelines.1
General principles of vascular
ultrasonography
Though cardiologists are very familiar to ultrasonography (US), they
must be aware that performing ‘good quality’ vascular US requires a
different skill set from echocardiography, a very strict methodology
and a formal time-consuming training. For each location (cervicoen-
cephalic, lower limb, and intracranial arteries), a minimal training of
100 exams per year is required. But cardiologists can learn a lot from
‘having a look at vessels’ which are a key element of the CV system.
This document will focus on the specific aspects of vascular US.
Probes
US probes vary in shape, size, and emission frequency. Table 1 illus-
trates the display. For difficult cases (obese patients, swollen limbs,
and highly calcified vessels), the ‘abdominal’ convex low-frequency
probe can be used for cervicoencephalic arteries (CEA) and limb ves-
sels examinations and the sectorial ‘cardiac’ probe for aorta
examinations.





























































Emission power, amplification gain, dynamic range, and velocity must
be individually pre-programmed for each application.
High-resolution B-mode scanning
High-resolution B-mode scanning (Figure 1) is used to display the
morphological features of vessels and surrounding structures (e.g.
muscles, bones).
DUS
DUS combines pulsed wave (PW) Doppler spectrum and B-mode
sonography. The width of the sample must equal half to two-thirds of
the vessel lumen. Peak systolic velocity (PSV) and velocity ratio are
basic elements in assessing arterial stenosis. In low-resistive arteries
(e.g. internal carotid, vertebral, renal arteries), the end diastolic vel-
ocity (EDV) is measured (Figure 2) and the resistance index (RI) can
be calculated: RI = (PSV – EDV)/PSV [In high resistive arteries (e.g.
limb arteries), EDV is not taken into account (close to zero).]. RI is
useful in specific circumstances (e.g. internal carotid arteries, renal ar-
tery stenosis, haemodialysis fistula).
Colour Doppler flow imaging
Colour Doppler flow imaging (Figure 3) preserves the advantages of
conventional US adding colour-coded blood flow patterns. The col-
our code depends on the direction of blood flow (see the scale on
the corner of the screen) and on the average mean velocity of moving
blood cells within the sample volume at a given point in time.
Power Doppler sonography
Power Doppler displays the strength of the Doppler signal in colour,
rather than the speed and direction information (Figure 4). Its sensitiv-
ity for detection of flow is three times higher than conventional col-
our Doppler, making this technique particularly useful for small
vessels and for low-velocity flows, especially for the display of echolu-
cent or anfractuous plaques. Being less angle dependent than colour
Doppler, it gives a better display of curving or tortuous vessels.
Unlike colour Doppler, it is not altered by aliasing. Its main disadvan-
tage is a lack of information on blood flow direction.
eFlow and B-flow
eFlow (HITACHI-ALOKA) is a blood flow imaging mode having high
spatial resolution and high-temporal resolution. In addition, it enhan-
ces the processing to discriminate blood flow from tissue (Figure 5).
The directional eFlow offers blood flow information with high reso-
lution. B-flow (GE) directly images blood reflectors and tissue
information simultaneously. eFlow and B-flow give a very precise dis-
play of the vessel wall and the plaque.
The angle of insonation
The angle of insonation (angle of incidence, theta or h angle) is the
angle between the incident ultrasound beam and the blood velocity
vector (Figure 6). The velocity vector must be parallel to the artery
axis if there is no stenosis or a moderate one, and parallel to the sten-
osis flow direction if the stenosis is more severe and oblique. In col-
our and PW Doppler, h angle must be <60 (usually between 45 and
60) in order to avoid overestimation of blood velocity.
Assessment of arterial stenosis
Arterial stenosis is characterized by a high PSV, a high EDV in low-re-
sistive vessels with severe stenosis, a high systolic velocity ratio (SVR,
PARTIM I, Carotid Arteries, DUS, Infrainguinal Bypasses, Post-
Transluminal Percutaneous Angioplasty/Stenting Surveillance
Sections), colour Doppler aliasing, spectral broadening of the
Doppler waveform and post-stenotic turbulence. Colour aliasing
occurs when the flow velocity exceeds the Nyquist limit. It guides the
placement of the spectral Doppler sample volume in case of stenosis.
Arterial velocity and SVR are the most reliable tools used to detect
and quantify arterial stenosis provided that h angle is <60 .
Contrast enhanced US
Currently, SonoVueVR (sulfur hexafluoride with a phospholipid shell)
(Bracco, introduced in 2001) is the only contrast agent used in
Europe for contrast enhanced ultrasonography (CEUS) of vascular
lesions. Current vascular indications are transcranial Doppler (TCD),
display of neovascularization in unstable plaques or leak detection
after endovascular aorta repair (EVAR). With US contrast agents the
incidence of severe hypersensitivity or anaphylactoid reactions is
lower than with current X-ray ones and is comparable to that of MR
.................................................................................................
Table 1 Transducer frequencies typically used for
ultrasound examination
Superficial veins Linear probe 10–14 MHz
Cervicoencephalic vessels Linear probe 7.5–10 MHz
Abdomen (adult) Convex probe 3.5 MHz
Transcranial Doppler/
heart (adult)
Sectorial probe 2–3 MHz

























































.contrast agents. US contrast agents are not licensed in pregnancy.
Caution should be exercised in patients with severe coronary artery
disease (CAD) and pulmonary hypertension. Unstable CAD in the
7 days prior to administration is a relative contraindication.2 These
contraindications derive from unproven causal association between
contrast injection and death in severely compromised cardiac
patients. The association has not been found in very large cohorts
including acute cardiac patients.
CEA examination
Normal examination
DUS is usually the first-line imaging choice for the evaluation of CEA,
especially for atherosclerosis. Main indications are listed in Table 2. In
order to avoid misleading results, DUS should include thorough
examination with a standardized protocol. A high frequency
(>_7 MHz) linear probe will be used, but for short and/or thick necks,
a lower frequency (3–5 MHz) curviline probe (‘abdominal probe’)
may be useful. Positioning of the patient is important in order to en-
sure operator’s comfort and performance. In most cases, the oper-
ator is seated at the head or at the side of the patient.
Scanning is performed in both cross sectional and longitudinal
views and must include evaluation of the entire course of the access-
ible portions of the common carotid artery (CCA), the external ca-
rotid artery (ECA), the internal carotid artery (ICA), the vertebral
artery (VA), and the subclavian artery (SCA) bilaterally. The examin-
ation should start with B-mode imaging. In order to screen for
anechogenic and/or irregular plaques, imaging must be completed by
colour Doppler (Power Doppler, eFlow, or B-flow, if available and
necessary). PW Doppler is mandatory too.
Anatomical description is beyond the scope of this document. It
should be noted, however, that there are up to 35% of anatomical
variants, including branching, level of carotid bifurcation (CBif), length,
coiling, and kinking of the arteries.3
Figure 2 Severe internal carotid artery stenosis with aliasing (arrow on colour Doppler) and high peak systolic and end-diastolic velocities (pulsed
wave Doppler).
Key points
(1) Dedicated probes and pre-sets must be used according to the
application.
(2) The blood velocity vector must be aligned with the blood flow
direction and the angle of insonation (angle of incidence, theta
or h angle) must be <60.
Figure 3 2D echo and colour Doppler flow imaging: carotid
bifurcation.
Key points
Scanning should include cross-sectional and longitudinal views of
the entire course of the accessible portions of the CCA, ECA
and ICA, VA, and SCA bilaterally, in B-mode and colour-Doppler.







































































CCA can be imaged from its origin from the brachiocephalic trunk
on the right side and from the aortic arch on the left side, to its ending
at the CBif. ICA can be imaged at its origin at the end of the CBif and
should be followed as high as possible. (Figures 3 and 7) The ECA can
be differentiated from the ICA by the presence of branches and a
higher RI (Figure 8).
Figure 5 eFlow with better display of of an echolucent plaque.
Figure 6 Angle of insonation.
Figure 4 Power Doppler sonography showing an anfractuous
plaque in the internal carotid artery.
Table 2 Main indications for Duplex ultrasounds of
cervicoencephalic arteries
Symptoms • Stroke/TIA
• Visual disturbances/amaurosis fugax




Clinical examination • Cervical bruit
• Discrepancy in blood pressure taken in
both upper extremities
Surveillance • >50% carotid stenosis
• Carotid endarterectomy or stenting
Cardiovascular risk
assessment
• In intermediate risk patients
Screening • Patients with coronary artery disease
and/or lower extremity artery disease
(see PARTIM II)
• Personal history of neck irradiation
Arteritis • Giant cell disease, Takayasu disease
Cervical/head trauma




















































































































































Flow velocities, measured with a h angle <_60 , must be recorded
in standard locations: proximal CCA (close to the clavicle), mid-
CCA, and distal CCA (just before the CBif), ECA, proximal, mid and
distal extracranial ICA.
The proximal ICA is a frequent site of stenosis and requires special
attention. The distal extracranial ICA should be sampled as high as
possible. Often a posterior approach (posterior to the sternocleido-
mastoidian muscle) is better than an anterior one. PSV and EDV must
be measured at each standard ICA site (and at stenotic sites). The ca-
rotid ratio is calculated by dividing the maximal ICA PSV by the distal
CCA PSV. Normal values are as follows: ICA PSV <125 m/s, ICA EDV
<40 m/s, and carotid ratio <2.
In tortuous vessels, correct alignment of the US beam with blood
flow direction can be more difficult and lead to overestimated PSV,
mimicking stenosis.
Vertebral arteries
In most patients, VAs are congenitally asymmetrical with unilateral
hypoplasia (<2.2 mm) or atresia [without vertebrobasilar (VB) con-
fluence]. VAs are anatomically divided into three extracranial por-
tions (V0 = ostium, V1 between V0 and V2, and V2 in the vertebral
transverse processes) and one intracranial portion (V4). The visual-
ization of V0–V1 with US is possible in approximately 65–85% of the
cases, but it is the most frequent location of atherosclerosis. If there
is any suspicion of VA stenosis, effort must be made to sample as
close to the VA origin as possible.
To visualize the VA, the sonographer must first image the mid
CCA longitudinally from an anterior approach, then slide the
transducer posteriorly until parts of V2 appear between the acoustic
shadows of the vertebral transverse processes (Figure 1). After
obtaining this B-mode image, colour Doppler must be added to as-
sess the direction of flow, and then PW Doppler, in order to evaluate
the waveform shape and record PSV. Normal vertebral flow is paral-
lel to CCA flow. Normal PSV values for V2 are approximately 20–
60 cm/s and slightly higher at the origin of the VA. RI is higher in the
case of V4 atresia and V3 occlusion.
Subclavian arteries
Recording of SCA flow is part of the CEA examination. Normal
waveform is triphasic.
Atherosclerosis
Usually atherosclerosis develops gradually. The first structural change
in the arterial wall is an increase in the thickness of the intimal and
medial layers [intima-media thickness (IMT)], with reduced elasticity
and increased arterial stiffness. Later, atherosclerotic plaques form
and grow. They can protrude into the lumen, leading to arterial sten-
osis. At any stage of the chronic process, ‘acute’ atherosclerotic
events can interrupt this development and lead to CV complications.
As DUS can usually give accurate structural and haemodynamic infor-
mation, it is usually considered as the first-line imaging technique. MR
and/or CT angiography may be necessary in the case of poor echoge-
nicity (e.g. thick neck, heavy calcifications) or when carotid endarter-
ectomy (EA) is considered. They should be associated when carotid
artery stenting (CAS) is considered or in the case of stroke.
Intima-media thickness and plaques
Examination of the carotid wall gives an opportunity to evaluate sub-
clinical alterations in wall structure that might precede CV clinical
events.
Intima-media thickness
Carotid IMT has been widely used in trials and in clinical use, but one
of its major issues is discrepancy in methodology.4,5 Currently its sys-
tematic use in CV risk assessment is no longer recommended by the
ESC guidelines on CV prevention 2016.6 Anyway, we think that
standard measurement criteria need to be briefly described here.5
Focus depth (30–40 mm), frame rate (>15–25 Hz), and gain set-
tings should be adjusted in order to optimize edge detection.
Figure 8 External carotid artery (2D echo and pulsed wave Doppler).
Key points
(1) The ECA can be differentiated from the ICA by the presence of
branches and a higher RI.
(2) The carotid ratio is calculated by dividing the maximal ICA PSV
by the distal CCA PSV.
(3) Normal values are: ICA PSV <125 m/s, ICA EDV <40 m/s, and ca-
rotid ratio <2.
(4) Correct alignment of the US beam with blood flow direction is
mandatory.




















Measurement must be taken in diastole. The CCA must be placed in
a horizontal position in a longitudinal view with clearly defined
lumen-intima and media-adventitia interfaces (perpendicular to the
US beam). The posterior approach offers the best resolution.
Insonation from multiple angles and zooming are not recommended.4
The usual site of measurement is the posterior wall of the CCA at
least 5 mm below the distal end of the artery, in a segment free of ath-
erosclerotic plaque.
Measuring IMT in the CCA gives better quality images and better
intra- and interobserver reproducibility, but as the CCA is less prone
to atherosclerosis than the CBif, it leads to underestimation of the
real atherosclerotic burden.
IMT should be measured automatically or semi-automatically
(150–200 measurements along a 10-mm arterial segment).6
Measurements should be made in triplicate and IMT values averaged
(Figure 9). Reproducibility of IMT measurement increases when val-
ues from both CCA are combined. Serial studies of IMT to assess
progression or regression in individual patients are not
recommended.5,6
IMT progresses with increasing age and all known CV risk factors
(RFs) accelerate this progress. IMT values are significantly higher in
men than in women as well as on the left side compared to the right
one. Reference values differ from one country to another and defin-
ing cut-offs is a controversial topic. For the American Society of
Echocardiography Task Force, IMT >_75th percentile is indicative of
increased CV risk, and values from the 25th to the 75th percentile
are indicative of unchanged CV risk. There are also more conserva-
tive cut-off suggestions: IMT values >_ age-adjusted 97.5th percentile
to be defined as abnormal (and predictive of increased vascular risk).7
Carotid plaques
Carotid plaques can be present separately or concomitantly with
increased IMT. According to the Mannheim Carotid Intima-Media
and Plaque Consensus, plaques are focal structures encroaching into
the arterial lumen of at least 0.5 mm, or 50% of the adjacent wall
thickness, or demonstrating a thickness >1.5 mm as measured from
intima-lumen to media-adventitia interfaces.5
In order to detect eccentric plaques and measure maximal plaque
size, screening requires scanning of the entire cervical carotid tree
and visualization in both longitudinal (multiple angle approach) and
cross-sectional views at the sites of focal atherosclerosis.5,6 Location,
thickness, and number of plaques should be recorded. Plaques typic-
ally develop first in the CBif and the proximal ICA. Colour Doppler
with careful adjustment of the velocity scale is mandatory to detect
echolucent and/or irregular plaques.6 Power Doppler, e-flow, and
B-flow must be used if available. (Figures 4 and 10).
Presence of plaques further adds to the CV risk assessment be-
cause they have a better specificity than IMT alone. According to the
ESC guidelines on CV disease 2016, carotid artery plaque assessment
may be considered to be a risk modifier in CV risk prediction in some
cases.6 Plaque characterization could have some prognostic implica-
tions on stroke. (PARTIM I, Surveillance After Surgery section).
Key points
(1) Due to the lack of standardization regarding the definition and
measurement of IMT, its high variability and low intra-individual
reproducibility, the systematic use of carotid IMT in CV risk as-
sessment is no longer recommended by the ESC guidelines on
CV prevention 2016.
(2) Serial studies of IMT to assess progression or regression in indi-
vidual patients are not recommended.
Figure 9 IMT measurement in the common carotid artery.
Figure 10 Echolucent plaque in a common carotid artery (longi-
tudinal view).
Key points
(1) Plaques are focal structures encroaching into the arterial lumen
of at least 0.5 mm or 50% of the surrounding IMT value, or dem-
onstrating a thickness >1.5 mm as measured from intima-lumen
to media-adventitia interfaces (Mannheim Consensus).
(2) Plaques have a better specificity for CV risk assessment than
IMT alone and may be considered to be a risk modifier in CV




















































































































Stenosis and occlusion of carotid arteries
Due to turbulence and shifts in shear stress flow dividers and branch
points of the CEA are more prone to develop stenotic lesions. These
parts are mainly the CBif and the origin for the VA.
Carotid artery stenosis/occlusion
ICA stenosis. Apart from highly calcified lesions, stenoses can often be
evaluated by direct 2D echo measurements with the use of colour
Doppler and if possible, Power Doppler, eFlow, or B-Flow imaging
(Figure 5). Settings must be optimized and rigorous cross sectional
view is mandatory. Longitudinal views may be useful too if the sten-
osis is not too eccentric.
There are several methods of measurements of carotid stenosis.
The most widely used are the North American Symptomatic Carotid
Endarterectomy Trial Collaborators’ (NASCET)8 and the European
Carotid Surgery Trialists’ (ECST)9 methods (Figure 11). As the
NASCET method is better related to haemodynamics and angiog-
raphy, it is proposed as the standard method. On the other hand, the
ECST method is better related to plaque burden. The area method
(Figure 12) can be used too. Interestingly, using the ECST or the area
method must be clearly mentioned as they both overestimate the
stenosis (Table 3).
Compared with CT-scan or MR, the main asset of US is the
haemodynamic data. The degree of carotid stenosis can be estimated
with ICA PSV, CCA EDV, and carotid ratio (ICA PSV/CCA PSV). There
are several tables for estimation of ICA stenosis according to veloc-
ities. One of the most widely used was the Society of Radiologists in
Ultrasound Consensus (San Francisco 2002).10 According to the
results of carotid stenosis trials (NASCET, ACAS), ICA stenoses
were classified as <50%, 50–69%, >70% stenosis, near-occlusions,
and occlusions. Grading carotid stenosis using US has been reviewed
in 2012 (Table 4).11 In >50% ICA stenosis, PSV is >125 cm/s. EDV
mostly increases in >70% stenosis (Figure 2). In order to avoid errors
due to special haemodynamic conditions [low/high cardiac output
(Low/high cardiac outputs, respectively decrease/increase PSV in the
CEA.), aortic stenosis (Severe aortic stenosis decreases PSV in the
CEA.), contralateral carotid severe stenosis or occlusion (Carotid se-
vere stenosis or occlusion increase the PSV in the contralateral ICA.),
collateral flow. . .], 2D echo, ICA PSV, ICA EDV, and carotid ratio must
all be integrated. Gender differences in blood velocities across ca-
rotid stenosis should also be considered.12
Colour Doppler can help detecting severe carotid stenosis by
showing aliasing (Figure 2).
In the case of severe stenosis (>80%) or occlusion of the ICA,
TCD may be useful. The ipsilateral middle cerebral artery (MCA)
Doppler waveform is usually altered unless collateralization via the
Willis circle is fully functional. Most of the time, PSV are asymmetrical
(>30% variation between the right and left MCA flows) and/or the
time to peak velocity is >70 ms on the side of the stenosis. The ipsilat-
eral RI may be lowered due to compensatory vasodilation. If TCD is
not available, the ophtalmic artery (OphtA) flow must be checked
(To perform PW Doppler measurement of OphtA, a 1.5–4.0 MHz
linear transducer is positioned on the closed eyelid with minimal
pressure. The OphtA is identified as a large caliber vessel adjacent to
the optic nerve. The sample volume marker lay approximately 40–50
mm from the eyelid.) (Figure 13). Severe ICA stenosis will lower oph-
talmic PSV (>30% asymmetry) or reverse the OphtA flow (from the
eyeball to the origin of the ophtalmic nerve).
Figure 11 The NASCET/ECST methods of measuring carotid
bulb stenosis: A, B, and D are measured with colour Doppler; C is
the normal lumen diameter before the development of the stenosis.
Figure 12 The area method of measuring carotid stenosis.
.................................................................................................
Table 3 Grading of carotid stenosis according to
NASCETand ECST







































































































.Compared with conventional angiography the sensitivity and speci-
ficity of DUS for detection or exclusion of ICA stenosis >_70% range
between 85 and 90%.
The morphological characteristics of the stenosis could also have
some prognostic and therapeutic implications, but they are subjective
and not sufficiently validated. In fact, echolucent stenoses are sup-
posed to be more at risk than iso- or hyperechogenic ones because
they usually correspond to lipid deposits, intraplaque necrosis, or
haemorrhage. An irregular surface with anfractuosity may correspond
to an ulcerated unstable plaque. As blood flow velocities are low in
anfractuous lesions, they are better detected by Power Doppler,
eFlow, or B-Flow with adapted filters and velocities (Figure 4).
CCA stenosis. CCA stenosis is less common and less well studied than
ICA stenosis. It can result from atherosclerosis, inflammatory proc-
esses [Takayasu disease, giant cell arteritis (GCA)], or from scarring
(e.g. after neck irradiation) and has been linked to stroke and transi-
tory ischaemic attack (TIA) too. The diagnostic criteria for significant
CCA stenosis are unclear though doubling of PSV between adjacent
segments has been suggested as for other vascular sites. According to
a retrospective analysis, comparing DUS with CT, DUS evaluation is
highly sensitive, specific, and accurate for detecting lesions in mid and
distal CCA. PSV >180 cm/s and EDV >30 cm/s performed as most
accurate criteria for detection of >_50% CCA stenosis.13
Carotid artery occlusion. It can be a final step in the gradual process of
atherosclerotic plaque evolution but it can also be due to local plaque
destabilization with thrombosis or to a large embolus. In the case of
carotid artery occlusion, DUS demonstrate the absence of flow and
an occlusive thrombus in the lumen (Figure 14). Indirect signs of ICA
occlusion are a slower and more resistive flow in the ipsilateral CCA
(pulsus parvus) (Figure 15), a flow inversion in the ipsilateral OphtA,
and a damped flow in the ipsilateral MCA. In some cases, an ‘internal-
ized flow’ (similar to normal ICA flow) in the ipsilateral ECA can mis-
lead the operator.
....................................................................................................................................................................................................................
Table 4 Combined criteria for grading internal carotid artery stenosis
% stenosis 10–40% 50% 60% 70% 80% 90% Occlusion
PSV threshold 125 cm/s 230 cm/s
PSV average <_160 cm/s 210 cm/s 240 cm/s 330 cm/s 370 cm/s Variable
PSV post-stenotic >_50 cm/s <50 cm/s <30 cm/s
Collateral flow (circle of Willis/ophtalmic artery) þ - þ þ þ
EDV in the stenosis <100 cm/s >100 cm/s
Carotid ratio <2 >_2 >_2 >4 >4
According to von Reutern et al.11
EDV, end diastolic velocity; PSV, peak systolic velocity.
Figure 13 Ophtalmic flow.
Key points
(1) Whenever possible ICA stenosis must be estimated in colour-
Doppler (or eFlow, B-Flow, or Power Doppler) and PW
Doppler.
(2) The standard measurement method is the NASCET method.
(3) Echolucent and/or anfractuous carotid plaques are supposed to
be more at-risk of stroke.















































































Pitfalls in assessment of ICA stenosis.14 Evaluation of CEA can some-
times be challenging and requires awareness of some common
pitfalls.
• Gender: ICA PSV is generally higher in women than in men
(Table 5).
• Carotid stents decrease vessel compliance and increase blood vel-
ocity in the vessel (PARTIM I, follow-up after CAS section).
• Tandem lesions: in the case of 2 consecutive lesions, blood vel-
ocity may be reduced between the leskions. This should be sus-
pected when there is a discrepancy between B-mode images and
PSV. In such a case, the second lesion should be sought for. If it is
intracranial, TCD, CT-scan, or MRI need to be performed.
• A long stenosis can lower PSV and lead to underestimation of the
severity of the stenosis. 2D echo may help avoid this pitfall.
• Very severe ICA stenosis: ICA PSV increases exponentially with the
severity of the ICA stenosis, before decreasing abruptly in very se-
vere stenosis. In that case, high ICA EDV is a sign of severe stenosis.
Indirect signs of severe ICA stenosis (TCD, OphtA) can also be
sought for, but CT-scan or MR angiography (MRA) may be
required to determine the degree of stenosis.
• Near-occlusion (near total occlusion, pseudo-occlusion): If the
ICA stenosis is very severe (‘hairline lumen’), it can be haemo-
dynamically equivalent to an occlusion with good collaterals. Intra-
and post-stenotic blood velocity is then very slow and can be
missed by DUS, especially if pulsed repetition frequency (PRF) is
set to detect higher flow velocities. This should be suspected with
every occlusion detected by US, especially if MCA flows are sym-
metrical. In order to differentiate near-occlusion from real occlu-
sion, gain should be set to avoid image noise. PRF and filter
settings must be lowered to detect very slow flows. Power
Doppler, eFlow, B-Flow, and CEUS could also help, but some-
times CT is necessary for the differential diagnosis. The gold stand-
ard for distinguishing a pseudo-occlusion from a true occlusion
remains conventional arteriography. DUS usually have a better
sensitivity than MRI (and sometimes CT-scan) in this indication.
• Aortic stenosis and proximal artery stenosis: if a stenosis is located
somewhere between the aortic valve and the proximal part of the
CCA, PSV is decreased in the CCA and the ICA (‘pulsus parvus
and tardus’ phenomenon). This can be observed bilaterally (aortic
valve stenosis) or unilaterally (stenosis of the brachiocephalic trunk
or the proximal CCA). In the case of severe stenosis or occlusion
of the right brachiocephalic trunk, blood velocities are lowered in
the right CCA, ICA, and ECA as well as in the right SCA with a
variable degree of subclavian steal syndrome.
• In case of severe calcification, flow velocities can be difficult to as-
sess. The operator can choose to measure velocities before and
after the calcification or try to view the vessel from another ap-
proach. The ‘abdominal probe’ is often very useful. Sometimes dif-
ferent imaging modalities are required (MRI).
• Contralateral carotid occlusion or severe stenosis: flow velocities
are usually higher because of increased collateral flow.
• Anatomic variants: some anatomic variants may affect the quality
of duplex carotid scanning. A tortuous carotid artery (coiling or
kinking) can lead to overestimation of PSV. That is why perfect
alignment with the flow direction is mandatory. A high CBif or a
short neck can impede the examination of the ICA and tilting the
probe posteriorly may be helpful. Another anatomic variant is the
persisting trigeminal artery (remnant of the foetal cerebral circula-
tion that bridges the carotid and basilar arterial territories) which
Figure 15 Resistive flow in the common carotid artery due to an
occlusion of the ipsilateral internal carotid artery.
Figure 14 Occlusive thrombus in the CCA.
.................................................................................................
Table 5 Gender differences in blood velocities across
65–75% unilateral carotid stenosis
Men (cm/s) Women (cm/s)
PSV 231 ± 12 295 ± 17
EDV 78 ± 7 101 ± 8












































..reduces flow resistance in the ICA with high EDV and low RI (nor-
mal range 0.7–0.9).
Vertebral arteries
Non-invasive imaging of the VA is less well studied than that of ca-
rotid arteries although atheromatous changes develop with a similar
frequency in both anatomic locations. Though a stenosis of the VA
can be clinically suspected, it is often diagnosed incidentally, whereas
imaging CEA for other causes.
Vertebral stenosis is often located at the origin of the artery and
may be detected by a delayed rise time in the post-stenotic segment
(indirect sign) or by direct insonation of the origin of the artery and
detection of focal velocities >100 cm/s. VA occlusion is more difficult
to diagnose and differentiate from congenital aplasia or hypoplasia.
2D echo can help. Distal obstructions of the VA (V3) can be detected
by a demonstration of a high resistive flow—pulsus parvus in V2.15
TCD can confirm the cervical vertebral occlusion by recording a re-
verse flow in the ipsilateral intracranial VA (V4).
In many cases, US detection of an ostial VA stenosis is difficult.
Dedicated probes may help but CTA and contrast-enhanced MRA
have higher sensitivity and specificity. Catheter-based contrast angi-
ography remains the gold standard of VA imaging for revasculariza-
tion candidates,3 but indications are rare.
SCA stenosis may alter vertebral flow by causing subclavian steal
syndrome. This pathology is described in PARTIM II.
Surveillance of asymptomatic carotid stenosis on best medical treatment
According to the 2017 ESC-ESVS guidelines,1 carotid EA should be
considered in patients with an asymptomatic 60–99% ICA stenosis
with average surgical risk (<3%) and life expectancy >5 years (IIaB) if
an increased risk of late ipsilateral stroke is suspected. This recom-
mendation is validated by data suggesting that the risk of stroke with
‘BMT alone’16 is lower than what was reported in previous studies
like ACAS or ACST. Targeting the at-risk patient who will benefit
from carotid surgery or stenting and considering ‘BMT alone’ for the
majority have become burning issues. For patients under BMT alone,
surveillance of the carotid stenosis and evaluation of stroke risk have
become increasingly important.
Unlike the severity of an asymptomatic carotid stenosis, its pro-
gression (>20%) is a risk predictor of stroke and TIA, and of a com-
posite endpoint of myocardial infarction, percutaneous coronary or
peripheral intervention, coronary or vascular surgery, amputation,
stroke, and all-cause mortality. A first 6-month, DUS will identify a
progression of the stenosis, leading to an adaptation of the
therapeutic strategy. In the case of non-progression, surveillance can
be scheduled every 12–18 months.
According to Geroulakos et al.17 (Table 6), plaque characterization
can also be predictive of stenosis progression and clinical events:
hypoechoic, heterogeneous, and irregular plaques are risk markers of
CV events, especially stroke and TIA. As hypoechoic plaques are at
higher risk of progression, Geroulakos’ Type 1, 2, and 3 carotid pla-
ques should be followed more closely. Other features associated
with increased risk of stroke are: contralateral TIA/stroke, spontan-
eous embolization on TCD monitoring (HITS), impaired cerebral re-
serve, large plaques, intraplaque haemorrhage or lipid-rich necrotic
core (MRA).
Surveillance after carotid surgery
Up to about 2 years after surgery, restenosis is generally attributed to
neointimal hyperplasia with accumulation of smooth muscle cells and
fibrous tissue. The risk of stroke is usually low. Later, restenosis is
generally caused by recurrent atherosclerosis with increased macro-
phage infiltration, calcification, and lipid core resembling primary pla-
ques with higher risk of stroke or TIA. An isoechoic, concentric
plaque is in favour of neointimal hyperplasia, whereas atherosclerotic
lesions are more heterogeneous and eccentric, mimicking a primary
plaque.
Key points
(1) VA stenosis is often located at the origin of the artery.
(2) VA stenosis may be detected by a delayed rise time in the post-
stenotic segment or by focal velocities >100 cm/s.
(3) VA occlusion is more difficult to diagnose and differentiate from
congenital aplasia or hypoplasia.
(4) V3 obstructions can be detected by a high resistive flow in V2
.and a reverse flow in the ipsilateral V4.
Key points
(1) EA should be considered in patients with an asymptomatic 60–
99% ICA stenosis with average surgical risk (<3%) and life ex-
pectancy >5 years, if an increased risk of late ipsilateral stroke is
suspected (IIaB, 2017 ESC-ESVS guidelines).
(2) Features associated with increased risk of stroke are: contralat-
eral TIA/stroke, stenosis progression (>20%), HITS, impaired
cerebral reserve, large and/or echolucent plaques, increased
juxta-luminal black (hypoechogenic) area, intraplaque haemor-
rhage, or lipid-rich necrotic core (MRA).
(3) A first 6-month, DUS will identify a progression of the stenosis.
In the case of non-progression, surveillance can be scheduled
every 12–18 months.
(4) Hypoechoic plaques (Geroulakos’ Type 1, 2, and 3) should be
followed more closely.
.................................................................................................
Table 6 Characterization of the carotid plaque
Type 1 Predominantly echolucent with a
thin echogenic cap
Type 2 Intermediate echolucent lesions with small areas of
echogenicity
Type 3 Intermediate echogenic lesions with small areas of
echolucency (<25%)
Type 4 Uniformly echogenic lesions (equivalent to homogenous)
Type 5 Cannot be classified (acoustic shadowing artefact)




















































































The PSV velocity cut-off for >60% restenosis is between 150 cm/s
and 220 cm/s. For EA with patch closing, restenosis cut-offs have
been proposed by AbuRahma et al.18 (Table 7) It is noteworthy that
the mean PSV of a normal ICA distal to carotid EA patching is higher
than normal carotid arteries.
Protocols of surveillance in the different trials and guidelines rec-
ommend DUS at 1, 3, 6, 12 months, and then annually. However,
considering the low risk of recurrent stenosis or occlusion after EA, a
periprocedural control followed by a yearly surveillance should be
sufficient in most cases. In at-risk population (women, diabetics,
smokers) and in patients with an ipsilateral restenosis >_50%, contra-
lateral disease progression is more frequent and surveillance may be
appropriate.
Follow-up after carotid stenting
According to several studies (EVA-3S,19 CREST, ICSS. . .), CAS and
carotid EA are associated with low and similar long-term (up to
10 years) risks of recurrent ipsilateral stroke beyond the procedural
period.
Different reports indicate that CAS may cause a reduction of com-
pliance resulting in an increase of blood velocity despite any resten-
osis. Therefore, velocity cut-offs are higher for CAS. Furthermore,
DUS velocities could be higher when using closed cell stents as com-
pared with open cell stents. Different thresholds of PSV have been
proposed for high-grade in-stent restenosis. Based on the current
available literature, a PSV value of 300–350 cm/s and a carotid ratio
>4–4.5 could be used as relatively good and sensitive predictors of
high-grade in-stent restenosis. Table 8 proposes cut-offs for in stent
re-stenosis.20
Immediate post-stenting DUS examination provides a baseline
value for future surveillance comparisons. According to the literature,
DUS can be recommended at 1, 6, 12 months, and then annually.
Arteritis
Giant cell disease
GCA disease can affect supraaortic arteries in two ways:
The ‘temporal arteritis’ or ‘Horton’s disease’ mainly involving tem-
poral arteries. It can coexist with GCA of the CEA, but is usually lim-
ited to temporal arteries.
The second type which is mainly located in the subclavian, axillary
and brachial arteries with a consecutive involvement of the CCAs
and ECAs. Temporal arteries are usually not affected by arteritis in
that circumstance (PARTIM II).
DUS is the first-line imaging technique for GCA. PET-CT and MRA
can be associated in ‘extra-temporal’ involvement.
The examination of temporal arteries should start at the origin of
the common superficial temporal artery and continue as far as pos-
sible to the distal area of the frontal and parietal ramus. Both sides
need to be examined. Flow velocities may be measured, but except
for stenosis, they provide no additional information for the diagnosis.
In temporal arteritis, there is a typical hypoechoic dark area around
the perfused lumen (‘halo sign’) due to oedema of the artery wall,
and sometimes there is a consequent stenosis of the temporal
arteries (Figure 16) in the acute phase.21 The halo disappears within
2–3 weeks after starting steroid therapy. Scanning has always to be
displayed both in longitudinal and cross-sectional views. The use of
modern scanners with high resolution is essential (longitudinal linear
12 or 14 MHz transducers). The colour intensity must be adapted in
order to avoid overpainting that could mask the hypoechoic halo.
Lesions detected by US usually show the typical pattern of skip
lesions (consecutive short lesions separated by normal unaffected
portions due to segmentary arteritis). US can also detect occluded
vessels. In this case, the artery can be found by grey scale US with no
.................................................................................................
Table 7 Peak systolic velocity, end diastolic velocity,
and carotid ratio cut-offs for restenosis after carotid
endarterectomy with patch
PSV (cm/s) EDV (cm/s) Carotid ratio
>30% 155 41 1.64
>50% 213 60 2.25
>70% 274 80 3.35
According to AbuRahma et al.16
EDV, end diastolic velocity; PSV, peak systolic velocity.
Key points
(1) Restenosis after carotid EA: upto about 2 years after surgery, it
is generally attributed to neointimal hyperplasia (low risk of
stroke). Later, restenosis is generally caused by recurrent ath-
erosclerosis (higher risk of stroke).
(2) The PSV cut-off for >60% restenosis is between 150 and
220 cm/s.
(3) Protocol of DUS surveillance after carotid EA: 1, 3, 6,
12 months, and then annually or at least, a periprocedural con-
trol followed by a yearly surveillance except in ‘at-risk
population’.
.................................................................................................









>_30% >150 >42 1.5–2.5
>_50% >220 >88 2.7–3.4
>_80% >320 >119 4.1–4.5
According to AbuRahma et al.20
EDV, end diastolic velocity; PSV, peak systolic velocity.
Key points
(1) A PSV value of 300–350 cm/s and a carotid ratio >4–4.5 could
be used as relatively good and sensitive predictors of high grade
in-stent restenosis.
(2) After carotid stenting, DUS can be recommended at 1, 6,



































































































colour Doppler signal in the obliterated lumen. The sensitivity of
temporal artery DUS is 87% with regard to the clinical diagnosis, and
the specificity is about 96%. Pre-operative temporal DUS can guide
the biopsy. In the case of positive DUS, biopsy might not be
necessary.
Takayasu disease
Though patients with Takayasu disease are notably younger, GCA
and Takayasu have close similarities in terms of thickening of the ves-
sel wall and response to steroids with some overlap in the pattern of
involved arteries.22 However, Takayasu most commonly affects the
left post-vertebral SCA, CCAs, and renal arteries (branches of the
aorta) and never involves the temporal arteries. Both entities may in-
volve the aorta (PARTIM II). In Takayasu elastic fibres are destructed
(elastophagia), sometimes leading to aneurysm and fibrosis can lead
to stenosis and sometimes thrombosis.
Imaging usually associates DUS, CTA, MRA, and PET-CT.
The typical Takayasu lesion identified by DUS is a long, smooth,
homogeneous concentric thickening of the arterial wall, usually more
hyperechogenic than in GCA (‘Macaroni’ sign). In contrast, an athero-
sclerotic plaque is shown to be non-homogeneous, often calcified
and associated with an irregular vessel wall (Figure 17).
DUS may be more sensitive than any other diagnostic procedure,
through its ability to detect the intima-media thickening (resolution
of 0.1–0.2 mm in CCA) associated with early pre-stenotic lesions in
the CCAs and SCAs (‘prepulseless’ disease). The high resolution of
DUS raises the possibility that it may also help monitoring disease ac-
tivity and response to treatment.22 Carotid contrast echo allows
dynamic assessment of carotid wall neovascularization, which is a po-
tential marker of disease activity.23 Sadly, though widely available, the
use of high-resolution DUS is relatively underinvestigated in
Takayasu disease.
Carotid/VA dissection
CEA dissection is a major cause of ischaemic stroke in young and
middle-aged adults (mean age 45 years).24 It can occur after major
and minor head and neck trauma, but other RF have been proposed
such as hypertension and fibromuscular dysplasia (FMD) (PARTIM I,
FMD section). Though genetic factors probably act as parts of a
multifactorial predisposition, a monogenic connective tissue disease
(vascular Ehlers–Danlos syndrome, Loeys–Dietz syndrome) is rarely
found.
DUS is a widely available and quick non-invasive diagnostic tool for
dissection diagnosis, but it requires much experience and expert
training. In ICA dissection, a mural haematoma is located in the arter-
ial wall and causes a stenosis primarily located in the post-bulbar part
of the artery. This portion of the ICA may be studied with a curvilin-
ear probe,25 but in many cases only indirect DUS signs are present
Figure 17 Ultrasound image of a right common carotid artery
with typical multilayer thickening of vessel wall in Takayasu disease.
Key points
(1) GCA can affect supraaortic arteries in two ways: ‘temporal ar-
teritis’, also named ‘Horton’s disease’, mainly limited to tem-
poral arteries, and arteritis mainly located in the subclavian,
axillary, and brachial arteries with a consecutive involvement of
the CCAs and ECAs, and sometimes of the aorta.
(2) In GCA, DUS show a typical skip lesion with a hypoechoic dark
area around the perfused lumen (‘halo sign’). This sign disap-
pears within 2–3 weeks after starting steroids.
Figure 16 Giant cell arteritis: colour Doppler image of an
inflamed temporal artery. The black region surrounding the red
zone in the image shows the characteristic « halo sign ».
Key points
(1) Takayasu disease most commonly affects the left post-vertebral
SCA, CCAs, and renal arteries, and never involves the temporal
arteries. It may involve the aorta.
(2) Takayasu disease onset is usually at an age of 40 years.
(3) DUS show a long, smooth, homogeneous concentric thickening
of the arterial wall, usually more hyperechogenic than in GCA
(‘Macaroni’ sign).




















































































































































(increased or decreased pulsatility or bilateral blood flow velocity dif-
ference of >50%). VA dissection causes a stenosis or occlusion in ap-
proximately 80% of all cases but the sensitivity of DUS is even slightly
lower in the vertebral circulation compared to the anterior circula-
tion. This implies that both positive and negative US findings should
be confirmed by MRI (or CT). Whenever possible, TCD should be
added in order to evaluate the haemodynamic repercussions of ca-
rotid/vertebral dissection.
Recurrent dissections are two-fold more frequent than previously
thought, and follow-up (FUp) studies can preferably be done by
DUS.25 DUS are also useful for assessing re-opening of the artery or
regression of the stenosis during the FUp.
Fibromuscular dysplasia
FMD is a non-atherosclerotic, non-inflammatory vascular disease. It is
usually found in the renal (60–75%) and extracranial cerebrovascular
circulation (25–30%), but it has also been described in almost every
medium-sized or large artery of the body. It results in luminal narrow-
ing with or without associated aneurysm or dissection of the
media.26
FMD of CEA, including the VA, is often bilateral. The ICA is typical-
ly involved at the level of C1–C2 (mid to distal cervical ICA). FMD of
the CEA and SCA is more multifocal and bilateral than isolated RA
FMD. Patients with cerebrovascular FMD have a higher incidence of
intracranial aneurysms (especially intracranial ICA and MCA) recom-
mending the realization of cerebral MRI or CT-scan in those
patients.26
DUS can visualize velocity shifts and turbulences indicative of ar-
terial stenosis in the mid- to distal-cervical ICA and the VA. A « string
of beads » pattern may be identified too, although it is less common
and requires good US training. Although it may not be specific to
FMD, severe tortuosity (S curve) of ICA and/or VA in a less than
70 year old patient should also alert the sonographer. Because of the
distal location of the FMD, DUS examination of the entire ICA and
VA is mandatory, but currently, CT-scan is acknowledged as better
than MRA and DUS. Because of the nature and morphology of the
FMD lesions, DUS standard cut-offs used for grading of atheroscler-
otic carotid stenoses do not apply. Unfortunately we do not have
validated data yet.27
DUS can be an excellent modality for surveillance of carotid artery
FMD, but fortunately the disease is usually not progressive. DUS sur-




Increased IMT and higher grade of abnormality in the bulb wall were
observed at doses higher than 35 Gy.28 The relative risk of stroke has
been reported to be higher in patients treated for head and neck can-
cer compared with patients treated by radiation for breast cancer
patients or non-Hodgkin’s lymphoma. The risk of radiation-induced
carotid atherosclerosis increases with smoking and with the time
interval from radiotherapy. Routine US screening should be pro-
posed to patients who had received radiotherapy more than 5 years
previously.29
The disease is limited to (or more severe in) the irradiated area.
The diagnostic and grading of radiation-induced carotid athero-
sclerosis using DUS is based on the same principles as atherosclerotic
carotid artery stenosis grading and plaques morphologic description.




DUS is the mainstay in non-invasive lower extremity artery disease
(LEAD) imaging. The complexity and the accuracy of the examination
are influenced by the clinical context (Table 9). General principles of
US are of course applied for LEAD (PARTIM I, General Principles of
Vascular Ultrasonography section). A 5–10 MHz linear array trans-
ducer is used for limb examination. A low-frequency curvilinear
probe is preferred for aortoiliac screening or for enlarged or swollen
limbs. The patient is supine on a dedicated examination table with
the trunk slightly inclined at 30 , to allow relaxation of the muscles of
the abdominal wall. The arms are positioned along the body and the
legs should adopt a slight external rotation with discrete knee flexion.
The examination usually begins with the recording of the ankle ar-
tery flow and systolic blood pressure (SBP). The ankle brachial index
(ABI) is a simple method to confirm a suspected LEAD, and is also in-
dicative of the severity of the disease. The technical aspects of
ABI measurement are described in PARTIM I, Ankle-Brachial
Key points
(1) Immediate imaging of the cervical arteries should be performed
in all young or middle-aged adult patients with ischaemic stroke,
TIA, or transient monocular blindness.
(2) MRI is the first line imaging method, but US performed by an
experienced sonographer and completed by TCD can in most
cases give a fast and reliable diagnosis.
Key points
(1) Because of the distal location of the carotid FMD, DUS examin-
ation of the entire ICA is mandatory, and DUS probably has a
lower sensitivity than angiography and CT-scan.
(2) DUS standard criteria used for atherosclerotic carotid stenoses
do not apply in FMD.
(3) Due to a higher incidence of intracranial aneurysms (ICA and
MCA) in FMD, cerebral MRI, or CT-scan are recommended in
patients with such dysplasia.
(4) DUS diagnosis of vertebral FMD is challenging.
(5) For complete evaluation of cervical artery dissection, CTA and











































































Index section. The cut-off values of ABI values have been recently
adapted.30
The limb exploration is then continued segment by segment. It is
strongly recommended to fully evaluate one leg at a time rather than
compare both sides segment by segment. Iliac vessels are generally
assessed indirectly by the analysis of the Doppler waveform in the
common femoral artery (CFA). Direct examination of the iliac axis at
the end of the examination is of course recommended, mainly if an
iliac stenosis is suspected, but the patient morphotype or presence of
abdominal gas do not always allow it. Calf arteries can be evaluated in
detail but the examination is usually limited to the recording of the
ankle arteries flow. This is the order in which we advise to proceed:
ankle/pedal arteries, CFA, origin of the deep femoral arteries (DFA),
superficial femoral arteries (SFA), popliteal arteries (PopA) on both
legs with the linear probe, and then abdominal aorta (AA), external
(EIA), internal (IIA), and common iliac arteries (CIAs) with the curvi-
linear probe. In a normal examination, Doppler waveform is triphasic
from iliac to ankle arteries (Figure 18).
During image acquisition it is convenient to use a schematic repre-
sentation of the aortoiliac and LEA in order to annotate it and pro-
gressively reproduce an angiography-like description.
CFA
The CFA runs from the inguinal ligament to its division into SFA and
DFA, 3–6 cm distally. The CFA is detected in 2D echo and colour
Doppler is then added. It is located externally to the common fem-
oral vein. A normal Doppler signal is triphasic. An abnormal morph-
ology with increased rise time and/or damped signal suggests a
significant iliac disease (indirect sign).
The femoral bifurcation requires a detailed examination, as it is a
privileged site for atherosclerosis. The DFA runs postero-laterally to
supply the major thigh muscles. It should be scanned along its prox-
imal centimetres, as it is a major collateral pathway in patients with
significant SFA disease.
SFA
The SFA runs downwards along the antero-medial edge of the thigh,
anterior to the SFV. In the lower third of the thigh, it passes through
the adductor canal, becoming posterior to the femur. The examin-
ation begins at the femoral bifurcation and is carried along the length
of the thigh using colour Doppler. Doppler velocity waveform is se-
quentially recorded, as many times as necessary to check all points of
possible disease but at least in the upper, middle and lower thigh.
Specific attention is paid to the adductor canal where the SFA can be
the site of short stenosis or occlusion. In some cases, the use of a
lower-frequency curvilinear transducer (‘abdominal probe’) may be
helpful, as at this particular location the vessel is deep located.
Popliteal artery
In the popliteal fossa, the popliteal artery (PopA) is anterior to the
vein. Below the knee, it divides into the anterior tibial artery (ATA)
and the tibioperoneal trunk. The height of this division is variable.
Calf arteries
The posterior tibial artery (PTA) is easily accessible behind the medial
malleolus, where its position is constant, and then followed along the
leg. The peroneal artery runs deeply, lying closer of the posterior as-
pect the tibia and the interosseous membrane. The ATA is identified
through an antero-lateral approach. The detailed description of the
calf arteries may require the use of US contrast agents but most of
....................................................................................................................................................................................................................
Table 9 Levels of lower extremity artery ultrasonography
Level/accuracy of the examination Specific indications
Focused exploration Limited to the lesion site -Screening for LEAD in high risk asymptomatic patients (ABI)
-Screening for AAA-Early systematic follow-up after surgery
-Searching for complication of endovascular procedures (pseudoa-
neurysm, arteriovenous fistula, haematoma. . .)
Standard examination Definition and description of the location of
affected site(s)
-Symptomatic LEAD (intermittent claudication, critical limb ischae-
mia, abnormal peripheral pulse, arterial bruit. . .)




AAA, abdominal aortic aneurysm; ABI, ankle brachial index; LEAD, lower extremity artery disease.
Figure 18 Triphasic flow.
Key points
(1) ABI = ankle artery SBP/brachial artery SBP.

































































..the time they are simply evaluated by comparing Doppler velocity
waveform between the PopA and the ankle vessels.
Foot arteries
In foot blood flow is supplied by the ATA through the dorsalis pedis
artery (dorsal part of the foot) and by the PTA, dividing in medial and
lateral plantar arteries (plantar part). Diabetic arteriopathy typically
involves the tibioperoneal vessels, with sparing of the pedal vessels
(assisting pedal bypass).
Abdominal aorta
Optimally, the patient should be fasting for about 12 h (at least 6 h)
prior to the examination to limit interference by bowel gas, but it is
rarely so. The examination begins with the probe placed in a subcos-
tal position. The AA is located anterior to the vertebral bodies (L1–
L4), slightly left of midline. The AA is then progressively scanned
transversally and longitudinally from the diaphragm to the aortoiliac
bifurcation. The AA should be measured in a cross-sectional view
with the US beam perpendicular to the AA axis. The anteroposterior
and transverse diameters should be equal. If it is not possible to ob-
tain a circular section of the AA (in case of dilatation and/or sinuos-
ity), one can calculate the mean diameter of the ellipse or try to
measure the AA diameter in a good longitudinal view, provided the
diameter is perpendicular to the AA axis. Diameters are measured
from adventitia to adventitia. Alternative methods are described in
PARTIM I, AAA section. The anteroposterior diameter measurement
is more accurate than the transverse one because perpendicularity of
US confers a more precise display. In case of abundant bowel gas, the
patient is asked to turn on the left side and the transverse and longitu-
dinal diameters are then obtained in the coronal plane.
As the transducer is slowly moved caudally, the abdominal
branches of the AA are progressively identified: the celiac trunk divid-
ing into common hepatic and splenic arteries, the superior mesenter-
ic artery (1 cm distally to the celiac trunk), the right renal artery
emerging from the anterolateral portion of the aorta (generally seen
more easily than the left one), the left renal artery caudally and pos-
teriorly and finally, the inferior mesenteric artery.
Spectral Doppler analysis of intestinal arteries will demonstrate
different resistance waveform profiles, depending on the delay
relative to the last meal for ‘intestinal arteries’ (low-resistance profile
following a meal and normal resistance profile in fasting patients). The
normal renal artery spectral Doppler always demonstrates a low-
resistance waveform.
Iliac axis
As previously mentioned, the iliac vessels can firstly be indirectly eval-
uated from the CFA. A triphasic Doppler signal in the CFA of an
asymptomatic patient excludes an ipsilateral severe stenosis on the
iliac axis. If the anatomy is favourable, it is recommended to combine
waveform recording in the CFA with a direct examination. If neces-
sary, the patient is asked to turn on one side and then on the other.
The image acquisition sequence includes the examination of the aor-
tic bifurcation, the CIA, the iliac bifurcations, the EIAs, and ilio-
femoral junctions. Whenever it is possible, proximal IIAs should be
examined. As for lower limbs, it is recommended to evaluate one
side at a time.
Exercise testing
Eliciting symptoms through exercise may diagnose LEAD in patients
with typical exercise leg symptoms and normal (or near normal) ABI
by unmasking a lesion non-critical at rest that becomes significant on
exercise. Many exercise protocols exist. It is usually more convenient
to measure ABI with continuous wave (CW) Doppler. Patients with
symptomatic LEAD will demonstrate a fall in the ABI, directly corre-
lated to the severity of the occlusive disease (PARTIM I, Post-
Exercise ABI section).
Atherosclerosis
LEAD is mainly due to atherosclerosis. As a generalized process, ath-
erosclerosis typically involves both legs, though often not to the
same extent. Iliac stenoses/occlusions are located in the CIA, IIA,
and/or EIA. Most common sites of femoral artery atherosclerotic
lesions are the femoral bifurcation and the adductor canal. The DFA
mainly supplies thigh muscles. Though it is rarely affected by athero-
sclerosis distal to its origin, stenosis at its origin is more common in
patients with atherosclerosis of the femoral bifurcation and is clinical-
ly relevant in case of femoropopliteal (FP) occlusion, as DFA is the
principal SFA collateral. Occlusion of both the femoral and popliteal
arteries is also common.
DUS
Combined with ankle- or toe-brachial index, the major asset of DUS
is the haemodynamic estimation of the stenosis, which better corre-
lates with its ischaemic effects and patient’s symptoms, in contrast to
angiography that only provides morphological information.31 Apart
from acute critical ischaemia, DUS provides all the information neces-
sary for first-line management decisions in the majority of patients. It
can also differentiate atherosclerotic from non-atherosclerotic vascu-
lar diseases, and it is particularly useful for the FUp after surgical and
endovascular procedures.
Key points
(1) The anteroposterior and transverse diameters of the AA are
preferably obtained in a cross sectional view and should be
equal. Diameters are measured from adventitia to adventitia.
The anteroposterior diameter measurement is more accurate
than the transverse one.
(2) If the AA is dilated or tortuous, one can calculate the mean
diameter of the ellipse or try to measure the AA diameter (per-
pendicular to its axis) in a good longitudinal view, provided the
diameter is perpendicular to the AA axis.
Key points
(1) Non-critical lesions (especially iliac stenoses) can show a nor-
mal or near-normal ABI at rest.















































































































..Despite its great advantages, DUS is operator-dependent and
requires adequate qualification and training. Uniform training and
interaction with the surgical team is a requirement for large vascular
laboratories.
Performance of DUS may also be limited by obesity, bowel gas,
edema, surgical incisions, scars, ulcers, joint contracture, and arterial
calcification producing acoustic shadowing (calcified plaques, medial
arterial calcification).
Plaque/calcification
Atherosclerotic lesions appear on 2D imaging as irregularities of the
endothelial surface, intima-media thickening and plaques. They may
cause vessel stenosis. Atherosclerotic calcifications must be differen-
tiated from medial arterial calcinosis (MAC), which is not atheroscler-
otic (PARTIM I, MAC section).
Images are best obtained in the longitudinal axis of the vessels,
while transverse views may occasionally be used to define anatomic
relationships. Evaluation of plaque morphology is not a formal part of
DUS examination of LEAD at present.
Iliofemoral arteries are the most common location of atheroscler-
otic plaques especially in men and should probably be looked for as a
CV risk marker in intermediate risk people.32
Stenosis/occlusion
Technical modalities are described in PARTIM I, Normal examination
section. A preliminary survey enables identification of stenosis (tur-
bulent flow and aliasing in high-grade stenosis), occlusions and origins
of collaterals. Abnormal findings need to be confirmed and quantified
(Grading of Stenosis section—PARTIM I) in the longitudinal plane by
PW Doppler. In addition to colour-Doppler, Power Doppler imaging,
eFlow, or B-Flow can help.
PW Doppler waveform and PSV must be recorded at all the stand-
ard locations (CFA, proximal, middle and distal SFA, origin of the
CFA, PopA) and at any area of colour or grayscale abnormality
(lumen narrowing, plaque and/or flow disturbances such as aliasing,
turbulent jet, increased velocity), as well as in the arterial segment 2–
4 cm proximal (upstream) to any stenosis. PW Doppler spectra may
indirectly suggest the absence or presence of a tight stenosis up-
stream according to the triphasic or monophasic waveform, respect-
ively. In difficult cases a hyperaemia or stress test (treadmill or else) is
necessary to rule out significant aorto-iliac stenoses even with normal
or almost normal CFA waveforms.
Grading of stenosis
In lower limbs, the stenosis severity is assessed by its haemodynamic
consequences (Doppler) and not by its morphologic appearance. A
>_50% reduction in diameter is expected to increase PSV, proportion-
ally to the degree of stenosis.
Modifications of PSV, SVR (SVR = intra-stenotic/pre-stenotic PSV)
(direct criteria) and flow distal to the stenosis (indirect criteria) are
shown in Table 10 and discussed in detail below. In normal individuals,
PSV and arterial diameters decrease towards the periphery, while the
normal triphasic flow profile is preserved.30 As many other factors
may also affect PSV (e.g. SBP, reduced vessel wall elasticity, sympa-
thetic tone, presence of an upstream stenosis, collaterals), it is difficult
to define a PSV threshold for haemodynamically significant stenosis
and local SVR is preferred. A SVR >_2 is consistent with a >_50% sten-
osis and SVR >_3 with a >_70% stenosis. Distal to a medium/high-grade
stenosis or an occlusion, the normal triphasic flow profile is altered
with a post-stenotic decrease in PSV and increase in EDV due to
vasodilatation. A delayed systolic upstroke is also seen. Severe
below-knee lesions cause a significant discrepancy between ankle/
pedal and popliteal waveforms. It is noteworthy that normal triphasic
pattern may also change to monophasic waveform in case of normal-
ly occurring peripheral dilatation, caused by factors such as increased
muscle activity on exercise, fever, and local infection.
The haemodynamic effects of a stenosis also depend on a complex
interaction of different factors: presence of collaterals (see Effect of
Collaterals section), length or morphology of the stenosis, multiple
stenoses.30 Proximal to a high-grade stenosis, a pattern of high-
resistance flows immediately upstream the stenosis is reflected by an
increase in the reverse flow component (Pre-stenotic pulsatility may
also be reduced before sites of origins of collaterals.).
The extent and severity of LEAD must be characterized.
Morphologic findings, direct and indirect criteria that help identify
and quantify a stenosis (or an occlusion) should be included in the re-
port.33 Multilevel disease is very common in LEAD and should be
expected in patients with critical limb ischaemia. In these cases, flow
pattern should be investigated at short-length intervals and great care
should be taken in the assessment of lesions severity.
Effect of collaterals
Collateral arteries are often detected proximal and distal to a severe
stenosis or occlusion, as they tend to reconstitute the main arterial
trunk. Several pitfalls in DUS interpretation are related to the pres-
ence of collaterals:
• Flow from collaterals coursing parallel to the occluded artery may
be misinterpreted as flow within the occluded segment.
• If collateralization is poor, slow post-occlusive flow may lead to
over-estimation of the occluded segment.
• If collateralization is poor, the Doppler waveform distal to the oc-
clusion segment is damped with a large diastolic component,
resulting from peripheral dilatation in response to chronic
Key points
(1) The morphology of the waveform is important.
(2) In difficult cases a hyperaemia or stress test is necessary to rule
out significant aorto-iliac stenoses even with normal or almost
normal CFA waveforms.
Key points
(1) Morphologic findings, direct and indirect criteria that help iden-
tify and quantify a stenosis (or an occlusion) should be included
in the report.
(2) A local SVR >_2 is consistent with a >_50% stenosis and SVR >_3
corresponds to a >_70% stenosis.
(3) Multilevel disease is very common in LEAD and should be









































































peripheral ischaemia. The poorer the collateral situation, the more
monophasic the waveform and the lower the PSV become.
• Accelerated PSV in a collateral may be misinterpreted as a stenosis
due to the smaller diameter of the collateral.
• If collateralization is good, PSV in the stenotic segment may be
lower than expected (The flow volume in the immediate pre-
stenotic segment decreases with increasing flow through the
collaterals.).
• If collateralization is good, blood flow distal to an occluded seg-
ment can approach normal flow.
• In the case of CFA/EIA occlusion, flow may be reversed in the
DFA and supply ipsilateral CFA and/or SFA. In the case of CIA oc-
clusion, the same pattern can be seen in the IIA.
Doppler ultrasound protocols
Complete DUS scanning of the entire arterial network is labour- and
time-consuming, especially if infrapopliteal arteries are to be assessed.
In these cases and especially when a bypass is considered, another
imaging technique is usually required. However, even in this situation,
DUS can be an important aid in determining the most appropriate
site of anastomosis by identification of the least calcified portion of
the vessel. Consequently the protocol can differ according to clinical
questions as well as specific anatomic considerations. A short DUS
or a detailed artery mapping or a focused, limited examination may
be appropriate.
Short Doppler ultrasound protocol
A short protocol is used when all level waveforms are clearly tri-
phasic, with satisfactory ABI, in an asymptomatic patient. ABI and
angle-corrected spectral Doppler waveforms with velocity meas-
urements should be obtained bilaterally at a minimum, from
the following sites in the LEA: CFA, proximal SFA, mid SFA, distal
SFA, PopA. If clinically appropriate, imaging of the iliac, deep
....................................................................................................................................................................................................................





SVR Colour flow and wave-
form just distal to the
stenosis








Mild or low grade
stenosis (20–49%)
Triphasic waveform <2 Waveform is usually tripha-
sic
Minimal spectral broadening












partial filling-in of the







Monophasic with loss of
the reverse and diastol-
ic forward flow compo-
nents)













Amplitude normal or reduced
with increasing stenosis se-
verity (compared to other
side)
PIa increased immediately
proximal to a high-grade
stenosis
PIa may be reduced before
sites of collaterals origin
Occlusion (100%) No flow signal detectable
Length of occlusion may
be estimated by the
scan distance between







Very flat and reduced sys-
tolic peak
Monophasic
Amplitude very low ‘thump’
pattern immediately prox-
imal to the occlusion:
increased PIa, small complex
with low PSV and large
negative component
PIa reduced before sites of col-
laterals’ origin
Modified from Schäberle.31
EDV, end diastolic velocity; PI, pulsatility index; PSV, peak systolic velocity; SVR, systolic velocity ratio; V, velocity.
aPI = PSV-EDV/mean velocity.



























































































..femoral, tibio-peroneal, and dorsalis pedis arteries can also be
performed.
Short protocols may also vary according to the treatment plan,
being different for limb salvage, claudication, or emergency situations.
For example, patients with Stage II LEAD, most frequently do not re-
quire a full evaluation of the calf arteries below the tibiofibular trunk
as revascularization in this territory is not indicated at this stage. In
Stages III and IV LEAD, candidates for surgical revascularization above
the PopA may not require pre-operative digital substraction angiog-
raphy or DUS mapping of the infrapopliteal arteries provided that a
short protocol demonstrates a patent, non-stenotic popliteal seg-
ment and the primary surgical approach is not expected to be
affected by occlusions distal to the PopA or trifurcation.31
Long Doppler ultrasound protocol
A long DUS protocol, initially designed to mimic digital substraction
angiography, includes ABI and imaging of the aorta, iliac arteries, CFA,
SFA, DFA, PopA, calf, and pedal arteries. Such DUS protocols are
not often performed because they are time-consuming. However,
detailed arterial mapping may be particularly important in patients
with renal insufficiency to avoid angiographic contrast exposure.
A long DUS protocol may also be needed before an infrainguinal
bypass in order to select arterial segments for placement of proximal
and distal anastomoses. In these cases and in order to reduce scan-
ning time, a shorter protocol may stop at the most distal location of a
stenosis or occlusion that needs to be bypassed.
Ankle-brachial index
Methodology: ankle-brachial index ¼ ankle SBP/arm SBP
In normal patients, ankle-brachial index (ABI) is >1, since ankle SBP is
higher than arm SBP (because of the progressive pulse amplification
phenomenon when moving away from the heart.). In patients with
LEAD, the ABI tends to decrease as atherosclerosis spares upper
limbs arteries. An ABI <0.90 has 75% sensitivity and 86% specificity to
diagnose LEAD.34
The ABI can be used for two different (but not exclusive)
purposes:1
• First-line diagnostic tool when LEAD is suspected.
• Prognostic marker for CV events and mortality (e.g. to stratify the
risk of an asymptomatic individual with an intermediate CV risk
score).35
The major asset of the ABI is its high availability at low expense. It
requires a hand-held CW Doppler device or a DUS probe, and a
pressure cuff. The technical aspects for a standardized measurement
of the ABI are extensively presented in a recent consensus docu-
ment.35 The patient should rest for 5–10 min prior to the measure-
ment and keep lying still on his back. The pressure cuff is placed just
above the ankle (the direct application of the Doppler probe or the
cuff on wounded zones should be avoided). When the arterial
Doppler signal is detected, the cuff is inflated until the signal disap-
pears, and then slowly deflated. The Doppler signal reappearance
determines the SBP. This manoeuvre should be repeated bilaterally
at the sites of brachial arteries, PTA and ATA or DPA. If a SBP
difference >10 mmHg is found between both arms, a white coat ef-
fect must be suspected and brachial SBPs must be checked. If the
inter-arm SBP difference persists, the arm with the higher one will be
considered as the reference. Despite many attempts to validate alter-
native methods to measure ABI, mostly using oscillometric devices,
Doppler remains nowadays the standard reference {The oscillomet-
ric method [automated blood pressure (BP) cuffs] presents several
drawbacks, especially as it may overestimate pressure in case of low
ankle pressures, leading to missing some LEAD cases.}.36
The ABI of each leg should be calculated by dividing the higher of
the PTA or DPA SBP by the higher of the arms SBP. If assessing
LEAD, the ABI of each lower extremity should be taken into account
separately. Conversely when ABI is used to determine the CV risk,
the lower ABI between the two legs is retained as patient’s ABI. The
reproducibility of the ABI is acceptable when performed by a trained
physician/technician.
When LEAD is clinically suspected, an ABI >0.90 does not definite-
ly rule out the diagnosis, and further investigations, including post-
exercise ABI and/or US is necessary.
Post-exercise ABI
The ABI is first measured at rest, and then after exercise test (usually
treadmill test using Strandness protocol, at 3 km/h speed and 10%
slope), which is stopped when the patient reaches its maximal walk-
ing distance. A post-exercise ankle SBP decrease >30 mmHg or a
post-exercise ABI decrease >20% are diagnostic for LEAD.35
Surveillance
In non-revascularized patients with LEAD, ABI decreases slowly over
time as the disease progresses. Because of reproducibility issues, the
ABI change at an individual level is significant only if it exceeds ±0.15.
In trained but non-revascularized patients, ABI change is poorly cor-
related with symptoms evolution or functional performance. After
revascularization, ABI alone is insufficient to estimate the perfusion
amelioration and the risk of secondary thrombosis (An ABI increase
of 0.10 and 0.15 in the revascularized limb predicts no residual sten-
osis >50% with sensitivities of 79% and 67% and specificities of 92%
and 100%, respectively.37).
MAC
Occasionally ankle SBP and ABI are excessively high (ABI >1.40) or
even not measurable because of arterial incompressibility despite cuff
pressures as high as 250 mmHg (higher pressures are uncomfortable
and useless. They should be avoided.). These situations are related to
MAC (MAC is distinct from atherosclerosis as it does not occlude
the arterial lumen, unless it is associated with atherosclerosis, which
occurs in 40-50% of cases. Isolated MAC appears to have favourable
limb and general outcomes if not associated with occlusive LEAD.38)
(PARTIM I, MAC section), mostly observed in the very elderly, or in
the case of long lasting diabetes or renal failure with haemodialysis. In
this case, the toe-brachial index (TBI) is useful: TBI = toe SBP/hu-
meral SBP (Table 11). Toe SBP can be measured with photoplethys-
mography, LASER-Doppler or capillaroscopy. TBI normal values are
>_0.7.






























































































Aneurysms are the most frequent abdominal and lower extremity
disease after atherosclerosis. US assessment is pivotal for their detec-
tion and FUp. Patients with aortic or peripheral aneurysms are at high
risk for presenting aneurysms in other localizations, either simultan-
eously or over time, so that lifelong DUS assessment of other main
localizations is warranted.
Abdominal aortic aneurysm
The abdominal portion is the most frequent localization of aortic
aneurysms, mostly infra-renal. The most commonly accepted defin-
ition of abdominal aortic aneurysm (AAA) is a diameter >30 mm.39
Some authors propose a diameter exceeding 1.5 time the ‘expected
normal’ infra-renal aortic diameter, which can be estimated if the ad-
jacent portion is normal with parallel borders. This is suggested to
compensate for variations due to gender, as AA is on average 2 mm
smaller in women than in males. The 2014 ESC guidelines on the diag-
nosis and management of aortic diseases suggest indexing the aortic
diameter to body surface in outlier body size.39 At least, when AAA
diameter nears the thresholds for intervention, gender or body sur-
face should be taken into account.
The ESC guidelines recommend population screening of AAA by
US in men >65 years. It may also be considered in women >65 years
with a history of smoking. Targeted screening for AAA should also
be considered in first-degree siblings of a patient with AAA.39 Some
countries have developed population AAA screening programmes,
but this is still lacking in many countries. The ESC guidelines recom-
mend opportunistic US screening for AAA at the end of any trans-
thoracic echocardiography (TTE) performed in the population at risk
as defined above.39 DUS is the cornerstone method for the screening
and diagnosis of AAA and healthcare workers can be trained to
measure the diameter of the AA, even using portable machines. The
AA can be reliably imaged in >95% of subjects and AAA diagnosed
with excellent sensitivity and specificity.40 Because of the increased
risk of tandem lesions, patients with AAA should have thoracic aorta
imaging.41
AA scanning is described in PARTIM I, Abdominal Aorta section.
The most consensual measurement is the outer-to-outer anteropos-
terior diameter, as the evidence for the optimal threshold for inter-
vention is based on the external diameter.41 An alternative method
measuring inner-to-inner (internal) diameter is proposed, but this
diameter is on average 4 mm smaller that the external one, with simi-
lar reproducibility. The best reproducibility is found with the leading
edge-to-leading edge method. However, the diameters obtained by
the two latter alternative methods are more difficult to compare
with those obtained other imaging methods (CT, MRI). The transver-
sal diameter estimation by US should be considered with caution, as
the lateral edges of the aorta are less well delineated because non-
perpendicular to the US beam, leading to poorer measurement re-
producibility. When the largest diameter of the aneurysm is transver-
sal, it should be attempted to be measured by a lateral incidence (the
probe at the patient’s flank), or using another imaging method for
confrontation. In some cases, the aorta is very tortuous and the ac-
tual long axis of the vessel is difficult to determine. In this case, a longi-
tudinal view of the aorta can be proposed to determine the sagittal
diameter. Yet, in any report after AA echography, the exact diameter
(AP or any else), and the measurement method (external diameters
or alternative methods) should be clearly reported. This is of out-
most importance for the sake of comparison of the results to other
imaging methods, or when the aorta is repeatedly measured over
time to assess AAA growth.
Besides its diameter, AAA localization should be described, espe-
cially whether the RA are involved, and if not, the diameter of the
proximal neck and the distance between the RA and the proximal
neck. The presence of mural thrombus (Figure 19) should be
described. Similarly, the distal extension (whether it prolongs to an-
eurysmal iliac arteries) of the AAA should be mentioned too. All
these data are important for the suitability for proposing EVAR when
intervention is indicated. A full assessment of the peripheral arteries
distal to the AAA is recommended.39 But usually CT or MRI are man-
datory before intervention.
The ESC guidelines advocate surveillance rather than intervention
for AAA of 30–54 mm (the maximal threshold can be 50 mm in
Key points
• ABI = lower extremity higher SBP/upper arm higher SBP
• Normal value: 0.9 <_ ABI <_1.4 (on a lying patient)
• When LEAD is clinically suspected and ABI is >0.90, post-ex-
ercise ABI and/or US may be necessary. With the treadmill
test using Strandness protocol (3 km/h speed and 10% slope),
a post-exercise ankle BP decrease >30 mmHg or a post-exer-
cise ABI decrease >20% are diagnostic for LEAD.
• After revascularization, ABI alone is insufficient to estimate the
perfusion amelioration and the risk of secondary thrombosis
• ABI is also a prognostic marker for CV events and mortality.
The lower ABI between the two legs is retained as patient’s
ABI
• FUp: The ABI change at an individual level is significant only if
it exceeds ±0.15.
• Occasionally ABI is >1.40 or even not measurable because of
arterial incompressibility (MAC). TBI can assess distal flow in
those cases.
.................................................................................................
Table 11 Ankle-brachial index, toe systolic blood
pressure, and toe-brachial index
Normal Abnormal
ABI 1–1.4 <_ 0.9
(0.91–0.99: borderline)
>1.4: non-compressible arteries – unreliable
Toe SBP 120 ± 20 mmHg
TBI >0.7
ABI, ankle brachial index; SBP, systolic blood pressure; TBI, toe-brachial index.

















































women, in a case by case discussion).39 They propose necessary
intervals between repeated US imaging, according to the initial aortic
diameter. Beyond the diameter, a rapid growth (>10 mm/year or
>5 mm in 6 months) is considered at high risk of rupture and inter-
vention is then indicated.
US may diagnose ruptured AAA, but its performance should not
delay further imaging (CT) and referral to the operative room.
After open repair, DUS can be useful to assess the proximal and
distal anastomosis and the patency of vessels involved during the sur-
gical procedure, although the performance is lower during the post-
operative days because of intra-abdominal gas interpositions and sur-
gical wound. After the first year, long-term US surveillance of the
prosthetic graft is recommended at loose intervals.
Long-term DUS surveillance can even be more useful after EVAR,
especially in the absence of any complication (sac enlargement or
endoleaks) identified by CT during the first year, if the abdominal
imaging is satisfactory, with or without contrast media, to detect
long-term complications. In case of satisfying image in the hands of
experts, it can supplant CT beyond the first year of surveillance, but
the latter remains the gold standard if any doubt persists. In a meta-
analysis, colour-DUS presented 96% sensitivity and 85% specificity to
detect any type of endoleaks and 99% sensitivity and 100% specificity
to detect Type-1 or -3 endoleaks.42 Contrast media improve sensibil-
ity. Most endoleaks missed by DUS and contrast-enhanced US are
Type 2 endoleaks with no need for reintervention.
Popliteal artery aneurysm
Popliteal artery aneurysm (PAA) is generally defined by an increased
diameter >15 mm, but the best acknowledged definition is a loss of
parietal parallelism with a diameter exceeding 1.5 time the ‘expected
normal’ diameter. PAA are bilateral in 50% of cases and associated
with AAA in 40% of cases. So once a PAA is detected, AAA should
be systematically screened for.43 In contrast to AAA, the main com-
plication of PAA is not rupture but multiple repeated distal emboliza-
tion (Figure 20) leading to progressive rarefaction of the distal arterial
network prior to the clinical ischaemic presentation. These patients
are at high-risk of amputation.
DUS imaging is the method of choice to assess PAA and its compli-
cations. A thorough assessment is necessary, to confirm the diagnosis
and provide the maximal adventitia-to-adventitia diameter (either lat-
eral or AP) perpendicular to the vessels axis, after having eliminated
the other major differential diagnoses: large PopA (arteriomegaly),
adventitial cyst, synovial cyst, post-stenotic arterial dilation related to
an entrapped PopA, or a false aneurysm at the anastomotic site of a
bypass. It should also detect mural thrombosis (colour Doppler or
contrast media may be useful), and assess the distal arterial perme-
ability. During the same US imaging sequence, the full arterial vascula-
ture in both limbs must be assessed, and the venous repercussions
(thrombosis, compression with venous flow slowing) should be sys-
tematically evaluated.
A detailed description of all these parameters is essential when
surveillance (rather than intervention) is considered. When PAA
Figure 19 Aortic abdominal aneurysm with mural thrombus.
Key points
(1) Definition of AAA: diameter >30 mm or diameter exceeding
1.5 time the ‘expected normal’ infra-renal aortic diameter.
(2) US screening for AAA: men >65 years, women >65 years with a
history of smoking and first-relatives of patients with aortic
aneurysms (ESC). Opportunistic screening of AAA is recom-
mended at the end of any TTE performed in the population at
risk (ESC guidelines).
(3) Patients with AAA should have thoracic aorta imaging.
(4) The most consensual measurement is the outer-to-outer an-
teroposterior diameter.
(5) If the aorta is very tortuous, a longitudinal view of the aorta can
be proposed to determine the sagittal diameter. Yet, the meas-
urement method should be clearly reported.
(6) The ESC guidelines advocate surveillance rather than interven-
tion for AAA of 30–54 mm (the maximal threshold can be
50 mm in women, in a case by case discussion). A rapid growth
(>10 mm/year or >5 mm in 6 months) is also considered at high
risk of rupture.
(7) After open repair, long-term DUS surveillance is recommended
at loose intervals.
(8) After EVAR, especially in the absence of sac enlargement or
endoleaks identified by CT during the first year and in case of
satisfying image in the hands of experts, DUS can supplant CT
beyond the first year of surveillance. CT-scan remains the gold

































































diameter is <20 mm without thrombus, watchful waiting can be pro-
posed, with US reassessment every 6 months in the absence of any
symptom. PAA >30 mm and/or symptomatic PAA should be oper-
ated (endovascular or mostly open repair). Surgical repair can be
proposed for PAA between 20 and 30 mm if the operative risk is low,
the runoff is acceptable, if there is an adequate venous conduit or a
distorsion of the proximal conduit >45 (higher embolic risk). After
endovascular or surgical repair, regular US assessment of the oper-
ated site (and other arteries) is necessary.
Miscellaneous
MAC
Medial arterial calcification (MAC) can occur in otherwise normal
young patients, but it is common in elderly patients as well as in
patients suffering from diabetes mellitus, severe renal impairment, or
hypervitaminosis D. Unlike atherosclerotic calcification, which typic-
ally forms in the intima, MAC is located in the medial layers of the ar-
tery and does not obstruct the arterial lumen (Figure 21). It is
frequently encountered in aorta and in lower limb arteries (SFA,
PopA, and infrageniculate arteries). It can cause incompressibility of
ankle arteries with overestimated (>1.4) or unmeasurable ABI
(PARTIM I, MAC section).
Arterial embolism
Emboli most frequently lodge at aortoiliac or femoral bifurcations or
at popliteal trifurcation and abruptly stop blood flow. In case of acute
limb ischaemia, DUS can be performed rapidly and assess the level of
occlusion. Anyway imaging should not delay revascularization.
Arteritis
GCA and Takayasu disease are described in PARTIM I, Arteritis sec-
tion. They may affect the aorta and GCA sometimes extends to LEAs
causing intermittent claudication.
Buerger’s disease
Thromboangiitis obliterans (TAO) or Buerger’s disease is a non-ath-
erosclerotic, segmental, inflammatory disease that most commonly
affects the small and medium-sized arteries and veins of the upper
and lower extremities. US investigation is used to check for a lack of
Figure 21 Medial arterial calcinosis: hyperechogenic spots.
Key points
(1) DUS is the method of choice to assess PAA and its
complications.
(2) If PAA diameter is <20 mm without thrombus, watchful waiting
can be proposed, with US reassessment every 6 months in the
absence of any symptom.
(3) PAA >30 mm should be operated.
(4) Surgical repair can be proposed for PAA between 20 and
30 mm if the operative risk is low.
(5) After repair or reperfusion, regular US assessment of the oper-
ated site (and other arteries) is necessary.
Figure 20 Longitudinal view of a popliteal aneurysm with a large
and mobile thrombus (high risk of distal embolism).
Key points
(1) Medial arterial calcification is common in elderly patients as well
as in patients suffering from diabetes mellitus, severe renal im-
pairment or hypervitaminosis D.
(2) It can cause incompressibility of ankle arteries with overesti-
















































































































atherosclerotic lesions and can identify the distal sites of symptomatic
arterial occlusion and other sites of lesions. Measurement of toe SBP,
mostly with LASER-Doppler, and measurement of transcutaneous
oxygen pressure (TcPO2) can be used to confirm the severity of
ischaemia.
A typical pattern which some consider pathognomonic for the dis-
ease is the occurrence of ‘corkscrew collaterals’ that occur typically
in the calf and forearm region as a consequence of occlusion of the
native vessels. These corkscrew collaterals can be detected by US.
Surveillance after bypass grafting
DUS looks for early (<6 months) (early complications sometimes in-
fection) and late (>6 months) post-surgical complications. The aim of
this surveillance is a more effective prevention of graft thrombosis.
A comprehensive description of the procedure and previous DUS
examinations should be available to the sonographer before begin-
ning the exam. Unfortunately it is not always so! DUS includes ABI
measurement and complete arterial mapping of the lower limb.
According to the clinical context, remote sites (aortoiliac arteries,
contralateral limb arteries) will be examined too. Colour Doppler
findings will guide PW Doppler interrogation.
Aortobifemoral bypass
They may show stenosis, kinking, or pseudoaneurysm. FUp pro-
grammes are still debated.
Infrainguinal graft
For infrainguinal vein grafts, the entire length of the graft should be
imaged and PSV (with optimal angle of insonation) recorded in the
proximal native artery, at the proximal anastomosis, throughout the
graft segment, at the distal anastomosis and in the distal native vessel.
Stenosis, false-aneurysm, mural thrombus, kinking must be looked for
in longitudinal and cross-sectional views especially in the proximal
anastomosis graft segment. Aliasing in colour Doppler imaging can
help identify stenoses. PSV must be recorded in 3–4 graft sites with-
out stenosis and averaged to calculate the graft flow velocity (GFV).
Compression of superficial venous grafts by the probe must be
avoided. The SVR (SVR = PSVmax/PSVproximal to the stenosis) must
be calculated at sites of stenosis.
FUp programme is still controversial but DUS can be proposed
3 weeks, 6 and 12 months post-operatively, and then annually. The
surveillance should be individualized to the patient, type of bypass,
and duplex scan findings.
Elements of a surveillance programme after infrainguinal vein by-
pass grafting are shown in Table 12. According to Bandyk et al.,45 GFV
<40–45 cm/s and absent diastolic forward flow need prompt correc-
tion because they are associated with early graft occlusion. High-
grade stenoses (>70%) must be corrected too. Early moderate or
intermediate stenoses should be monitored and treated in case of
progression. Most stenoses develop within the first post-operative
year. They are often located within the mid-portion and at anasto-
motic sites of the venous graft.
Unlike vein grafts, prosthetic grafts fail more frequently because of
impaired native vessel outflow or poor arterial inflow. FUp pro-
grammes are even less standardized. DUS is advised in the immediate
post-operative period and at regular intervals for at least 2 years, tak-
ing the interval history (new symptoms), vascular examination, ABI at
rest and DUS modifications into account.46 High-grade stenoses




Early adverse events are rare except haematomas. They include
acute thrombosis, arterial dissection, distal embolism, cholesterol
embolism, and local complications of endovascular procedures (false
aneurysm, arteriovenous fistula). DUS is currently performed after
revascularization (1 and 6 months), often annually thereafter, and at
recurrence of symptoms. ABI measurement is mandatory but not
sufficient. After iliac stenting, native iliac arteries Doppler cut-offs are
used. After FP stenting, PSV should be <180 cm/s and SVR <2.5. SVR
Key points
(1) TAO or Buerger’s disease is a non-atherosclerotic, segmental,
inflammatory disease that most commonly affects the small and
medium-sized arteries and veins of the upper and lower
extremities.
(2) Measurement of toe SBP, mostly with LASER-Doppler, and
TcPO2 can confirm the severity of ischaemia.
(3) Corkscrew collaterals can be detected by US.
Key points
(1) FUp after bypass grafting looks for stenosis, false-aneurysms,
local recurrence of the disease or development of new arterial
lesions at remote sites.
(2) Autogenous vein grafts usually fail within their mid-portion and
at anastomotic sites. FUp programme is still controversial, but
DUS can be proposed 3 weeks, 6 and 12 months post-opera-
tively, and then annually. The surveillance should be individual-
ized to the patient, type of bypass, and duplex scan findings.
(3) For prosthetic grafts, FUp programmes are even less standar-
dized. DUS is advised in the immediate post-operative period
and at regular intervals for at least 2 years, taking the interval his-
tory (new symptoms), vascular examination, ABI at rest and
DUS modifications into account.
(4) Aortobifemoral bypasses may show stenosis, kinking or false
aneurysm.
(5) For infrainguinal bypasses, PSV must be recorded in 3–4 non-
stenosed graft sites and averaged to calculate the GFV. SVR
(SVR = PSVmax/PSVproximal to the stenosis) is calculated at sites
of stenosis.
(6) GFV <40 cm/s and absent diastolic forward flow need prompt
correction.
(7) >70% stenoses must be corrected.
(8) Intermediate and moderate stenoses should be monitored and














































































































>2 is commonly considered as predictive of >50% stenosis47 and
requires repeated DUS 2–3 months later. To determine >_80%, com-




DUS allow easy diagnosis showing a continuous turbulent flow from
the artery into the adjacent vein. Closure by US-guided compression
has been reported, but surgical repair or endovascular treatment
with covered stent is usually required.
Femoral false aneurysm
Blood flows through the injured arterial wall and dissects into sur-
rounding tissues to form a haematoma. If a communication between
this haematoma and the femoral artery remains patent, a back and
forth blood flow may persist creating a femoral false aneurysm (FFA).
DUS is the method of choice for diagnosis. Contrast-enhanced CT
will only (rarely) be used if US findings are equivocal. Typical US
findings include a collection adjacent to the femoral artery (sac) com-
municating with it through a small channel (neck). A high velocity
bi-directional jet through the neck and a swirling flow in the sac are
typically seen on colour flow imaging (Figure 22).
Some small FFA (<2–3 cm) may spontaneously clot over time, but
spontaneous resolution is unpredictable which has led to treat more
actively most of them. Simple compression with the US probe may
abolish flow through the ‘neck’ and cause thrombosis of the aneur-
ysm ‘sac’. Local analgesia is required because the procedure is painful
and involves successive 10 min compressions that are repeated until
the sac is thrombosed (up to 60 min). Success rates of 63–88% have
been reported.49
Currently US-guided thrombin injection may be recommended
for treatment of FFA although studies are relatively small and per-
formed in single-centers.50
This technique has a primary success rate >_95%.51 Under US con-
trol (7 MHz linear array transducer, B-mode, and/or colour Doppler
imaging) and aseptic condition, the tip of a 22-gauge spinal needle
connected to a 1 mL syringe filled with thrombin (preferably human
thrombin 1000 U/mL) is introduced in the sac, as far as possible from
the neck. After having checked the position of the needle by aspirat-
ing red blood, the thrombin is slowly injected until the thrombus fills
the sac. Thrombosis frequently occurs instantly or within a few sec-
onds and the colour flow disturbances disappear both in the sac and
the neck. Most FFA will be occluded with 500–1000 U of thrombin
but higher doses up to 6000 U were reported. In rare cases, throm-
bin injection can be immediately complicated by thrombosis of the
native artery and venous thrombosis. Delayed reperfusion of the FFA
may also occur in up to 6% of cases. Thrombin injection is not recom-
mended for upper arm false aneurysms. Another minimally invasive
technique using US-guided para-aneurysmal saline injection has been
described.52,53 It is faster than US-guided compression, and less likely
to cause vasovagal reactions. An 18-gauge needle connected to a
plastic syringe filled with 0.9% saline solution is introduced and the tip
is positioned within 2–5 mm from the ‘neck’. Then the saline solution
is slowly injected until the resultant tissue swelling completely oblit-
erates the FFA neck. After saline injection, manual compression is
....................................................................................................................................................................................................................
Table 12 Elements of a surveillance programme of infrainguinal vein grafts
Risk of occlusion Stenosis (diameter) PSV (cm/s) Velocity ratio
(stenotic PSV/prestenotic PSV)
GFV (cm/s) ABI reduction
Very high risk >70% >300 >3.5 <45 (or staccato) >0.15
High risk >70% >300 >3.5 >45 <0.15
Intermediate risk 50–70% 180–300 >2 >45 <0.15
Low risk <50% or none <180 <2 >45 <0.15
Modified from Bandyk.44
Key points
(1) DUS is currently performed 1 and 6 months after endovascular
revascularization, often annually thereafter, and at recurrence
of symptoms. ABI measurement is mandatory but not sufficient.
(2) Iliac stenting, native iliac arteries Doppler cut-offs are used.
(3) FP stenting, PSV should be <180 cm/s and SVR <2.5. SVR >2 is
commonly considered as predictive of >50% stenosis and
requires repeated DUS 2–3 months later.
Figure 22 Typical bidirectional flow recorded in the neck of a















































..applied for a 5-min period. A randomized study has compared US-
guided compression and para-aneurysmal saline injection showing
that both techniques are effective with a primary final success rate of
75% and 87.5%, respectively. FFA may also result from previous vas-
cular surgery or trauma. They need a specific treatment that is not
addressed in this article.
Acute aortic dissection
Acute aortic dissections are usually divided according to the Stanford
classification in Type A and B. Type A starts in the ascending aorta
and Type B in the descending aorta. Another classification, de
Bakey’s, describes Type I dissection when it involves both ascending
and descending aorta, Type II dissection when it includes the ascend-
ing aorta and the arch and Type III if it spares the ascending aorta and
the arch.
CT, MRI, and transoesophageal echocardiography (TOE) have
very high sensitivity and specificity for the diagnosis of acute aortic
dissection. The choice of the imaging method is often dependent on
local availability, expertise and clinical context. Bedside TOE may be
of great interest in the very unstable patient as well as in the post-
operative intensive care.
Diagnostic imaging techniques are well described in the 2014 ESC
guidelines.39
Popliteal entrapment syndrome
It is a rare syndrome caused by congenital abnormal relationship be-
tween the PopA and the muscle structures (mostly gastrocnemius or
popliteus muscle) in the popliteal fossa. According to Wright classifica-
tion, there are six distinct anatomical presentations of this syndrome.54
The most frequent symptom is intermittent claudication, unilateral or
sometimes bilateral, in a young athletic patient without CV risk.
Intermittent claudication is due to dynamic compression of the PopA
during exercise. In long-standing cases, patients may even present with
total thrombotic occlusion or aneurysmal degeneration of the PopA
and embolism.55 In 2D echo, the PopA is deviated from its normal
course and the PopA and vein are separated by a fibromuscular struc-
ture that keeps them apart. Except for patients with popliteal occlu-
sion or stenosis, baseline Doppler examination is normal. Therefore,
baseline DUS must be completed by a positional stress test showing
popliteal stenosis (increased blood velocity) and disappearance of the
pedal pulses with active dynamic compression (plantar flexion against
strong resistance).56 DUS can diagnose popliteal entrapment syn-
drome and guide CT or MRI but there is a significant false-positive
rate. Imaging must correlate to symptoms. Examinations should be
performed during the maximal training period.
Endofibrosis of the EIA
It is a rare disease exclusively affecting young (usually 20-–25-year-
old) endurance athletes (road cycling, marathon, triathlon runners).
Endofibrosis can be located in the CFA and CIA but the most com-
mon location is the EIA. Kinking (tight bend or curl of the vessel with
stenosis) or progressive stenosis of the iliac artery may be associated
and reduce blood flow to the lower limb and adversely affect per-
formance. Kinking is sometimes due to extreme vessel length. The
disease can be bilateral. DUS is usually normal at rest. In 2D examin-
ation (especially during provocative manoeuvres), arterial kinking is a
positive diagnostic finding.57 The predictive value of DUS is low even
in trained hands and baseline Doppler must be completed by an
exertional test mimicking real life conditions (e.g. running or cycling)
and reaching symptoms threshold. As for PopA entrapment testing
must be planned during maximal training period. Bilateral ABI are
compared at rest and immediately after maximal exercise. Baseline
SBP are usually normal. Immediate post-exercise Doppler shows a
marked decrease on the involved side. Following maximal exercise,
ABI is <0.5 in 85% of patients and is used as a key argument for diag-
nosis.58 For other authors, an ABI <0.66 at 1 min after heavy-load ex-
ercise is considered to be the optimal cut-off point and a difference
of 0.18 between legs is a useful additional diagnostic criterion.59 Post-
stress iliac stenosis also needs to be recorded by Doppler (high-vel-
ocity flow) and is usually associated to a systolic murmur. In some
cases, 2D echo can visualize homogeneous circumferential wall thick-
ening of the EIA. Baseline CT angiography may look almost normal
and should be completed by special manoeuvre (hyperflexion of the
thigh).
Provocative exercise tests and DUS can confirm flow limitation
before detailed assessment of abnormal anatomy with MRI and digital
substraction angiography. MRI with hip flexion has been shown to be
the best method to show kinking in the CIA.
Key points
(1) DUS is the method of choice for the diagnosis of complications
after endovascular procedures (haematoma, FFA, and arterio-
venous fistula).
(2) FFA is a collection adjacent to the femoral artery communicat-
ing with it through a small channel. A high-velocity bi-directional
jet through the neck and a swirling flow in the sac are typically
seen on colour flow imaging.
(3) US-guided compression with thrombin injection may be consid-
ered as the current ‘gold standard’ for treatment of FFA. US-
guided simple compression with the probe may cause throm-
bosis of the aneurysm, but it is time-consuming and local anal-
gesia is required.
(4) Thrombin injection is not recommended for upper arm false
aneurysms.
Key points
(1) It is a rare syndrome caused by congenital abnormal relationship
between the PopA and the muscle structures.
(2) The most frequent symptom is intermittent claudication, unilat-
eral or sometimes bilateral, in a young athletic patient without
CV risk. Baseline Doppler examination is normal. It must be
completed by a positional stress test, performed during the
maximal training period.
(3) In long-standing cases, patients may present with total throm-
botic occlusion or aneurysmal degeneration of the PopA and
embolism.
(4) DUS can diagnose popliteal entrapment syndrome and guide













































































































































































These multiple imaging modalities are necessary to identify those
most likely to benefit from surgery and to select a patient-adapted
surgery technique.60
Radiation-induced lower limb arteritis
It is a rare complication of radiotherapy with wall thickening of large
vessels. It may lead to stenosis and progress to occlusion of the ves-
sel, thrombus formation, ulceration, and distal embolization, several
years after radiotherapy. It is often difficult to distinguish radiation ar-
teritis from mere atherosclerosis especially in smoking patients, but
localization and confinement to an area previously irradiated, with
lack of similar lesions elsewhere, favours radiation as the cause.61 The
dose of radiation reported in the literature to be associated with this
unique clinical entity is 20–80 Gy60, and 39.5–80 Gy is specifically
mentioned for the iliac and femoral arteries.
Conflict of interest: none declared.
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